Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension

From: 4th International Conference of cGMP Generators, Effectors and Therapeutic Implications Regensburg, Germany 19-21 June 2009 Author details 1-Bayer Schering Pharma AG, Medicinal Chemistry Wuppertal, Pharma Research Center, 42096 Wuppertal, GermanyEMPTY 2-Bayer Schering Pharma AG, Cardiovascular...

Full description

Saved in:
Bibliographic Details
Published inBMC pharmacology Vol. 9; no. S1; p. P52
Main Authors Mittendorf, Joachim, Weigand, Stefan, Alonso-Alija, Cristina, Bischoff, Erwin, Feurer, Achim, Gerisch, Michael, Kern, Armin, Knorr, Andreas, Lang, Dieter, Muenter, Klaus, Radtke, Martin, Schirok, Hartmut, Schlemmer, Karl-Heinz, Stahl, Elke, Straub, Alexander, Wunder, Frank, Stasch, Johannes-Peter
Format Journal Article
LanguageEnglish
Published London BioMed Central 11.08.2009
BioMed Central Ltd
Subjects
Cells
Hypertension
Nitric oxide
Poster Presentation
Online AccessGet full text

Cover

More Information
Summary:From: 4th International Conference of cGMP Generators, Effectors and Therapeutic Implications Regensburg, Germany 19-21 June 2009 Author details 1-Bayer Schering Pharma AG, Medicinal Chemistry Wuppertal, Pharma Research Center, 42096 Wuppertal, GermanyEMPTY 2-Bayer Schering Pharma AG, Cardiovascular Research, Pharma Research Center, 42096 Wuppertal, GermanyEMPTY 3-Bayer Schering Pharma AG, DMPK, Pharma Research Center, 42096 Wuppertal, GermanyEMPTY 4-Roche, Nonnenwald 2, 82377 Penzberg, GermanyEMPTY 5-Santhera Pharmaceuticals Ltd., Hammerstrasse 47, 4410 Liestal, SwitzerlandEMPTY Supplemental Information:
ISSN:1471-2210
1471-2210
DOI:10.1186/1471-2210-9-S1-P52